Bougard Marine

Main Referenced Co-authors

BURTEA, Carmen (4)

KAHVECIOGLU, Zehra Cagla (4)

LAURENT, Sophie (4)

SAUSSEZ, Sven (4)

Vandecasteele, Samuel (4)

Main Referenced Keywords

apoptosis (3); EGFR (3); therapeutic peptide (3); targeted therapy (2); anaplastic thyroid carcinoma (1);

Main Referenced Unit & Research Centers

CMMI - Centre de Recherche en Microscopie et Imagerie Médicale (4)

Main Referenced Disciplines

Oncology (3)

Anatomy (cytology, histology, embryology...) & physiology (2)

Biochemistry, biophysics & molecular biology (2)

Chemistry (1)

Publications (total 4)

Search in publications

The most downloaded

31 downloads

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Sarah Peeters, Daubry, A., Laurent, S., Saussez, S., & Burtea, C. (06 February 2024). Toward the development of a novel drug using engineered peptides designed for EGFR-mediated drug delivery of an apoptosis inducer in anaplastic thyroid carcinoma [Paper presentation]. Télévie Seminar. https://hdl.handle.net/20.500.12907/48533

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Peeters, S., Laurent, S., Saussez, S., & Burtea, C. (22 October 2024). Novel approach in the treatment of anaplastic thyroid cancer using EGFR-and PIP3-targeted synthetic peptides to inhibit the PI3K/AKT/mTOR signaling pathway [Paper presentation]. 9th Annual Peptide Therapeutics Symposium, La Jolla, United States - California.

https://hdl.handle.net/20.500.12907/49921

https://hdl.handle.net/20.500.12907/48533

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Peeters, S., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (24 November 2023). Innovative drug delivery system using EGFR-targeted engineered peptides in anaplastic thyroid cancer treatment [Poster presentation]. PhD Day SFMBBM 2023, Liège, Belgium.

https://hdl.handle.net/20.500.12907/46851

Peer reviewed

Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Rogien, C., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (27 October 2023). Novel therapeutic approaches for EGFR-mediated drug delivery using engineered peptides in anaplastic thyroid cancer [Poster presentation]. Annual BACR Meeting 2023 Friday October 27th, CIRCADIAN CYCLE, CHRONOBIOLOGY AND CANCER, brussels, Belgium.

https://hdl.handle.net/20.500.12907/46914

Peer reviewed